Dexmedetomidine Pediatric Dose — ED Sedation
Dexmedetomidine is a highly selective alpha-2 adrenergic agonist that produces dose-dependent sedation, anxiolysis, and analgesia with minimal respiratory depression. It acts centrally to mimic natural sleep pathways, making it a valuable agent for procedural and non-procedural sedation in the pediatric emergency department. Its favorable respiratory profile distinguishes it from many other sedatives used in acute care settings.
Pediatric Dosing
- Loading dose: 2 mcg/kg IV administered over 10 minutes
- Maintenance infusion: 2 mcg/kg/hour IV continuous infusion
- Repeat loading: The loading dose may be repeated up to 2 additional times if adequate sedation is not achieved
Worked example — 20 kg child: Loading dose = 20 × 2 mcg/kg = 40 mcg infused over 10 minutes; maintenance = 20 × 2 mcg/kg/hour = 40 mcg/hour. If needed, the 40 mcg load may be repeated up to twice more per protocol.
Consult institutional protocol for maximum cumulative dose limits and duration of infusion guidance.
Indications and Clinical Context
Dexmedetomidine is indicated for procedural and non-procedural sedation in the pediatric emergency department, particularly when a cooperative or arousable level of sedation is desired. It is well-suited for imaging (e.g., MRI), wound management, or other procedures where preservation of airway reflexes and spontaneous ventilation is a clinical priority. Its use aligns with institutional ED sedation protocols and is supported by growing pediatric emergency medicine literature.
Because dexmedetomidine does not reliably provide deep sedation comparable to propofol or ketamine in all patients, the protocol allows for repeat loading doses to optimize sedation depth. Clinicians should assess sedation level between loads before administering additional doses.
Administration and Monitoring
Dexmedetomidine is administered exclusively via the intravenous (IV) route per this protocol. The loading dose must be given slowly over 10 minutes to reduce the risk of hemodynamic adverse effects, particularly transient hypertension followed by hypotension and bradycardia — the most clinically significant side effects. Continuous cardiorespiratory monitoring including heart rate, blood pressure, oxygen saturation, and respiratory rate is required throughout administration.
- Administer loading dose over exactly 10 minutes; do not bolus rapidly
- Monitor for bradycardia and hypotension, especially during and immediately after the load
- Have resuscitation equipment and reversal capabilities available per standard ED sedation policy
- Assess sedation level prior to each repeat loading dose
- Consult institutional protocol regarding concentration preparation and infusion pump settings
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.